Detection and prognostic impact of renal dysfunction in patients with chronic heart failure and normal serum creatinine

Domenico Scrutinio, Andrea Passantino, Rocco Lagioia, Daniela Santoro, Erasmo Cacciapaglia

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: Accurate identification of renal dysfunction (RD) is crucial to risk stratification in chronic heart failure (CHF). Patients with CHF are at special risk of having RD despite normal serum creatinine (SCr), owing to a decreased Cr generation. At low levels of SCr, the equations estimating renal function are less accurate. This study was aimed to assess and compare the prognostic value of formulas estimating renal function in CHF patients with normal SCr. Methods: We studied 462 patients with systolic CHF and normal SCr. Creatinine clearance was estimated by the Cockcroft-Gault (eCrCl) and glomerular filtration rate by the 4-variable MDRD equation (eGFR); eCrCl normalized for body-surface area (eCrCl BSA) was calculated. The primary outcome was all-cause mortality at 2 years. Results: Seventy five patients died. At multivariate Cox regression analysis, only eCrCl BSA was significantly associated with mortality (p = 0.006); eGFR (p = 0.24), eCrCl (p = 0.09) and BUN (p = 0.14) were not statistically significant predictors. The patients in the lowest eCrCl BSA quartile had an adjusted 2.1-fold (CI: 1.06-4.1) increased risk of mortality, compared with those in the referent quartile. Two-year survival was 70.4% in the lowest eCrCl BSA quartile and 89.7% in the referent quartile. Other independent predictors of mortality were ischemic etiology (RR: 2.16 [CI: 1.3-3.5], p = 0.0017), NYHA III/IV class (RR: 2.45 [CI: 1.51-3.97], p = 0.0003), LVEF <0.25 (RR: 3.38 [CI: 1.69-6.75], p = 0.014), and anemia (RR: 1.86 [CI: 1.16-2.99], p = 0.009). Conclusions: A sizeable proportion of CHF patients have prognostically significant RD despite normal SCr. Such patients represent a high-risk subgroup and can more accurately be identified by the CG formula corrected for BSA than the MDRD.

Original languageEnglish
Pages (from-to)228-233
Number of pages6
JournalInternational Journal of Cardiology
Volume147
Issue number2
DOIs
Publication statusPublished - Mar 3 2011

Fingerprint

Creatinine
Heart Failure
Kidney
Body Surface Area
Serum
Mortality
Systolic Heart Failure
Blood Urea Nitrogen
Glomerular Filtration Rate
Anemia
Regression Analysis
Survival

Keywords

  • Heart failure
  • Prognosis
  • Renal function

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Detection and prognostic impact of renal dysfunction in patients with chronic heart failure and normal serum creatinine. / Scrutinio, Domenico; Passantino, Andrea; Lagioia, Rocco; Santoro, Daniela; Cacciapaglia, Erasmo.

In: International Journal of Cardiology, Vol. 147, No. 2, 03.03.2011, p. 228-233.

Research output: Contribution to journalArticle

@article{f7662efccab9438184ed81328505cee0,
title = "Detection and prognostic impact of renal dysfunction in patients with chronic heart failure and normal serum creatinine",
abstract = "Background: Accurate identification of renal dysfunction (RD) is crucial to risk stratification in chronic heart failure (CHF). Patients with CHF are at special risk of having RD despite normal serum creatinine (SCr), owing to a decreased Cr generation. At low levels of SCr, the equations estimating renal function are less accurate. This study was aimed to assess and compare the prognostic value of formulas estimating renal function in CHF patients with normal SCr. Methods: We studied 462 patients with systolic CHF and normal SCr. Creatinine clearance was estimated by the Cockcroft-Gault (eCrCl) and glomerular filtration rate by the 4-variable MDRD equation (eGFR); eCrCl normalized for body-surface area (eCrCl BSA) was calculated. The primary outcome was all-cause mortality at 2 years. Results: Seventy five patients died. At multivariate Cox regression analysis, only eCrCl BSA was significantly associated with mortality (p = 0.006); eGFR (p = 0.24), eCrCl (p = 0.09) and BUN (p = 0.14) were not statistically significant predictors. The patients in the lowest eCrCl BSA quartile had an adjusted 2.1-fold (CI: 1.06-4.1) increased risk of mortality, compared with those in the referent quartile. Two-year survival was 70.4{\%} in the lowest eCrCl BSA quartile and 89.7{\%} in the referent quartile. Other independent predictors of mortality were ischemic etiology (RR: 2.16 [CI: 1.3-3.5], p = 0.0017), NYHA III/IV class (RR: 2.45 [CI: 1.51-3.97], p = 0.0003), LVEF <0.25 (RR: 3.38 [CI: 1.69-6.75], p = 0.014), and anemia (RR: 1.86 [CI: 1.16-2.99], p = 0.009). Conclusions: A sizeable proportion of CHF patients have prognostically significant RD despite normal SCr. Such patients represent a high-risk subgroup and can more accurately be identified by the CG formula corrected for BSA than the MDRD.",
keywords = "Heart failure, Prognosis, Renal function",
author = "Domenico Scrutinio and Andrea Passantino and Rocco Lagioia and Daniela Santoro and Erasmo Cacciapaglia",
year = "2011",
month = "3",
day = "3",
doi = "10.1016/j.ijcard.2009.08.042",
language = "English",
volume = "147",
pages = "228--233",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Detection and prognostic impact of renal dysfunction in patients with chronic heart failure and normal serum creatinine

AU - Scrutinio, Domenico

AU - Passantino, Andrea

AU - Lagioia, Rocco

AU - Santoro, Daniela

AU - Cacciapaglia, Erasmo

PY - 2011/3/3

Y1 - 2011/3/3

N2 - Background: Accurate identification of renal dysfunction (RD) is crucial to risk stratification in chronic heart failure (CHF). Patients with CHF are at special risk of having RD despite normal serum creatinine (SCr), owing to a decreased Cr generation. At low levels of SCr, the equations estimating renal function are less accurate. This study was aimed to assess and compare the prognostic value of formulas estimating renal function in CHF patients with normal SCr. Methods: We studied 462 patients with systolic CHF and normal SCr. Creatinine clearance was estimated by the Cockcroft-Gault (eCrCl) and glomerular filtration rate by the 4-variable MDRD equation (eGFR); eCrCl normalized for body-surface area (eCrCl BSA) was calculated. The primary outcome was all-cause mortality at 2 years. Results: Seventy five patients died. At multivariate Cox regression analysis, only eCrCl BSA was significantly associated with mortality (p = 0.006); eGFR (p = 0.24), eCrCl (p = 0.09) and BUN (p = 0.14) were not statistically significant predictors. The patients in the lowest eCrCl BSA quartile had an adjusted 2.1-fold (CI: 1.06-4.1) increased risk of mortality, compared with those in the referent quartile. Two-year survival was 70.4% in the lowest eCrCl BSA quartile and 89.7% in the referent quartile. Other independent predictors of mortality were ischemic etiology (RR: 2.16 [CI: 1.3-3.5], p = 0.0017), NYHA III/IV class (RR: 2.45 [CI: 1.51-3.97], p = 0.0003), LVEF <0.25 (RR: 3.38 [CI: 1.69-6.75], p = 0.014), and anemia (RR: 1.86 [CI: 1.16-2.99], p = 0.009). Conclusions: A sizeable proportion of CHF patients have prognostically significant RD despite normal SCr. Such patients represent a high-risk subgroup and can more accurately be identified by the CG formula corrected for BSA than the MDRD.

AB - Background: Accurate identification of renal dysfunction (RD) is crucial to risk stratification in chronic heart failure (CHF). Patients with CHF are at special risk of having RD despite normal serum creatinine (SCr), owing to a decreased Cr generation. At low levels of SCr, the equations estimating renal function are less accurate. This study was aimed to assess and compare the prognostic value of formulas estimating renal function in CHF patients with normal SCr. Methods: We studied 462 patients with systolic CHF and normal SCr. Creatinine clearance was estimated by the Cockcroft-Gault (eCrCl) and glomerular filtration rate by the 4-variable MDRD equation (eGFR); eCrCl normalized for body-surface area (eCrCl BSA) was calculated. The primary outcome was all-cause mortality at 2 years. Results: Seventy five patients died. At multivariate Cox regression analysis, only eCrCl BSA was significantly associated with mortality (p = 0.006); eGFR (p = 0.24), eCrCl (p = 0.09) and BUN (p = 0.14) were not statistically significant predictors. The patients in the lowest eCrCl BSA quartile had an adjusted 2.1-fold (CI: 1.06-4.1) increased risk of mortality, compared with those in the referent quartile. Two-year survival was 70.4% in the lowest eCrCl BSA quartile and 89.7% in the referent quartile. Other independent predictors of mortality were ischemic etiology (RR: 2.16 [CI: 1.3-3.5], p = 0.0017), NYHA III/IV class (RR: 2.45 [CI: 1.51-3.97], p = 0.0003), LVEF <0.25 (RR: 3.38 [CI: 1.69-6.75], p = 0.014), and anemia (RR: 1.86 [CI: 1.16-2.99], p = 0.009). Conclusions: A sizeable proportion of CHF patients have prognostically significant RD despite normal SCr. Such patients represent a high-risk subgroup and can more accurately be identified by the CG formula corrected for BSA than the MDRD.

KW - Heart failure

KW - Prognosis

KW - Renal function

UR - http://www.scopus.com/inward/record.url?scp=79951955294&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951955294&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2009.08.042

DO - 10.1016/j.ijcard.2009.08.042

M3 - Article

VL - 147

SP - 228

EP - 233

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

IS - 2

ER -